Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II indinavir plus chemotherapy for advanced classical Kaposi sarcoma
2007-000567-26Phase 2Completed
- Sponsor
- Istituto Superiore di Sanità
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indinavir in Kaposi sarcoma (KS), sponsored by Istituto Superiore di Sanità. Primary endpoints: Complete response rate at end of treatment, Response during indinavir maintenance and 4 more. Started Mar 2009; status: completed.
02
Drugs
indinavir
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on 2007-000567-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000567-26.